EQS Group-Ad-hoc: LifeWatch AG / Key word(s): Agreement
LifeWatch AG: LifeWatch: 5-year Corporate Integrity Agreement successfully
completed
06-Jun-2017 / 19:00 CET/CEST
Release of an ad hoc announcement pursuant to Art. 53 KR
--------------------------------------------------------------------------------
LifeWatch: 5-year Corporate Integrity Agreement successfully completed
Zug/Switzerland, June 6, 2017 - LifeWatch AG (SIX Swiss Exchange: LIFE), a
leading developer and provider of medical solutions and remote diagnostic
monitoring services in the digital health market, is pleased to announce that
LifeWatch Services, Inc., the US subsidiary of LifeWatch AG, has successfully
completed the five- year term of its Corporate Integrity Agreement (CIA).
In March 2012, LifeWatch entered into a Settlement Agreement with the U.S.
Department of Justice, Office of the Inspector General (OIG) agreeing to pay $18
million and operate under a five-year CIA. The case pertained to certain
sales-related activities. During the five-year period, LifeWatch operated under
the guidance of an Independent Review Organization and submitted reports of its
compliance activities, on an annual basis, to the OIG. Today that additional
oversight has come to an end with the successful completion of the five-year
CIA. LifeWatch's CEO Dr. Stephan Rietiker commented, "We are pleased to be able
to move past this chapter in the company's history. We are strongly committed to
delivering diagnostic cardiac monitoring services with the highest levels of
integrity, compliance and patient safety. The highest standards of ethics and
compliance are part of LifeWatch's DNA, and we will continue to use established
best practices developed during the OIG oversight as an integral part of
maintaining a comprehensive and effective compliance program."
For further questions:
LifeWatch AG, Andrew Moore, CFO
c/o Communicators AG , Ralph Spillmann
Mobile: +41 79 514 64 84
E-Mail: investor-relations@lifewatch.com
About LifeWatch AG
LifeWatch AG, headquartered in Zug and listed on SIX Swiss Exchange (LIFE),
Switzerland, is a leading healthcare technology and solution company,
specializing in advanced digital health systems and wireless remote diagnostic
patient monitoring services. LifeWatch's services provide physicians with
critical information to determine appropriate treatment and thereby improve
patient outcomes. LifeWatch AG has operative subsidiaries in the United States,
in Switzerland, Israel and Turkey, and is the parent company of LifeWatch
Services Inc., LifeWatch Technologies, Ltd. and LifeWatch Turkey Holding AG
(joint venture). LifeWatch Services, Inc. is a leading U.S.-based provider of
cardiac monitoring services. LifeWatch Technologies Ltd., based in Israel, is a
leading manufacturer of digital health products. LifeWatch Sağlık Hizmetlerine
A.S. is the operative Turkish subsidiary of LifeWatch Turkey Holding AG and
provider of mobile cardiac telemetry services in Turkey. For additional
information, please visitwww.lifewatch.com.
Sign up for customized e-mail alerts and documentation requests at
https://www.lifewatch.com/Investor-Relations/Alert-Service.html
This press release includes forward-looking statements. All statements other
than statements of historical facts contained in this press release, including
statements regarding future results of operations and financial position, the
business strategy, and plans and objectives for future operations, are
forward-looking statements. The words "believe," "may," "will," "estimate,"
"continue," "anticipate," "intend," "expect" and similar expressions are
intended to identify forward-looking statements. LifeWatch AG has based these
forward-looking statements largely on current expectations and projections about
future events and financial trends that it believes may affect the financial
condition, results of operations, business strategy, short-term and long-term
business operations and objectives, and financial needs. These forward-looking
statements are subject to a number of risks, uncertainties and assumptions. In
light of these risks, uncertainties and assumptions, the forward-looking events
and circumstances described may not occur and actual results could differ
materially and adversely from those anticipated or implied in the
forward-looking statements. All forward-looking statements are based only on
data available to LifeWatch AG at the time of the issue of this press release.
LifeWatch AG does not undertake any obligation to update any forward-looking
statements contained in this press release as a result of new information,
future events or otherwise.
THIS PRESS RELEASE IS NOT BEING ISSUED IN THE UNITED STATES OF AMERICA AND MUST
NOT BE DISTRIBUTED TO UNITED STATES PERSONS OR PUBLICATIONS WITH A GENERAL
CIRCULATION IN THE UNITED STATES. THIS PRESS RELEASE DOES NOT CONSTITUTE AN
OFFER OF SECURITIES OF LIFEWATCH AG OR ANY OF ITS SUBSIDIARIES FOR SALE IN THE
UNITED STATES, OR AN INVITATION TO SUBSCRIBE FOR OR PURCHASE ANY SECURITIES OF
LIFEWATCH AG OR ITS SUBSIDIARIES IN THE UNITED STATES. IN ADDITION, THE
SECURITIES OF LIFEWATCH AG AND ITS SUBSIDIARIES HAVE NOT BEEN REGISTERED UNDER
THE UNITED STATES SECURITIES LAWS AND MAY NOT BE OFFERED, SOLD OR DELIVERED
WITHIN THE UNITED STATES OR TO U.S. PERSONS ABSENT FROM REGISTRATION UNDER OR AN
APPLICABLE EXEMPTION FROM THE REGISTRATION REQUIREMENTS OF THE UNITED STATES
SECURITIES LAWS.
Additional features:
Document:http://n.eqs.com/c/fncls.ssp?u=PXOKULLMOF
Document title: 20170606_CIA completed_E_PDF_vf
--------------------------------------------------------------------------------
End of ad hoc announcement------------------------------------------------------
Language: English
Company: LifeWatch AG
Baarerstrasse 139
6300 Zug
Switzerland
Phone: +41 41 728 67 78
Internet: www.lifewatch.com
ISIN: CH0012815459
Valor: 811189
Listed: Regulated Unofficial Market in Berlin, Stuttgart; Open Market in
Frankfurt; SIX Swiss Exchange
End of Announcement EQS Group News Service
--------------------------------------------------------------------------------
580763 06-Jun-2017 CET/CEST
EQS Group-Ad-hoc: LifeWatch AG / Key word(s): Offer LifeWatch AG: Board of Directors of LifeWatch supports the improved offer by BioTelemetry 29-May-2017 / 07:00 CET/CEST Release of an ad hoc announcement pursuant to Art. 53 KR 577975 29-May-2017 CET/CEST ...
EQS Group-Ad-hoc: LifeWatch AG / Key word(s): Offer LifeWatch AG: BioTelemetry, Inc. announces extension of the main offer period for public offer for LifeWatch AG 24-May-2017 / 16:30 CET/CEST Release of an ad hoc announcement pursuant to Art. 53 KR 577337 24-May-2017 CET/CEST ...
EQS Group-Ad-hoc: LifeWatch AG / Key word(s): Offer LifeWatch AG: AEVIS VICTORIA SA accepts BioTelemetry's revised offer 24-May-2017 / 11:26 CET/CEST Release of an ad hoc announcement pursuant to Art. 53 KR 577035 24-May-2017 CET/CEST ...
plus
Ces informations peuvent également vous intéresser
Ces informations peuvent également vous intéresser